Skylinedx
1 known investors
SkylineDx develops molecular diagnostic tests based on gene expression analysis to assess disease risk and predict treatment response in oncology and hematology. The company serves healthcare providers and patients making treatment decisions, with a focus on bridging academic biomarker discoveries with commercially available diagnostics.